{"title":"Atypical MEGDHEL Syndrome: A Milder Phenotype With Hepatic Presentation and Failure to Thrive Associated With a Homozygous Nonsense Variant of SERAC1","authors":"Rita Marchante Pita, Raquel Amaral, Laura Vilarinho, Luísa Diogo, Isabel Gonçalves, Susana Nobre","doi":"10.1002/jmd2.70017","DOIUrl":null,"url":null,"abstract":"<p>MEGDHEL syndrome, caused by a <i>SERAC1</i> gene defect, is clinically defined as the association of 3-MGA-uria (MEG), deafness (D), hepatopathy (H), encephalopathy (E), and Leigh-like features (L). Clinical presentation typically begins in the neonatal period, with neurological symptoms becoming more evident by 2 years of age. Severe liver involvement has also been reported. We report the case of a 3-year-old boy with increased transaminases and failure to thrive of unknown cause. He was born prematurely at 35 weeks and needed neonatal intensive care support for 24 h due to transient tachypnea. At 18 months, laboratory investigations for failure to thrive revealed elevated transaminases without cholestasis, which persisted on subsequent evaluations. Abdominal wall collateral veins were found during physical examination, and the liver ultrasound revealed steatosis, prompting the decision to proceed with a liver biopsy. Common causes of chronic liver disease were ruled out. Following liver biopsy, performed under general anesthesia, he had an episode of unexplained decompensation (metabolic acidosis, hyperlactatemia, and 3-methylglutaconic aciduria). The aciduria persisted upon subsequent evaluation. Liver histology showed macro/microvesicular steatosis (25%), portal tract inflammation, and mild fibrosis. Cardiac evaluation, along with brain magnetic resonance imaging and spectroscopy, was normal. Further investigations revealed decreased hepatic activity of respiratory mitochondrial chain complexes and marginal mtDNA depletion (28.1%). Analysis of the <i>SERAC1</i> gene showed homozygosity for p.Y259* (c.777T>G, exon 9). This case report raises awareness for an atypical presentation of MEGDHEL syndrome associated with a homozygous nonsense variant of SERAC1 clinically characterized by mild hypertransaminasemia, failure to thrive, no neurological involvement, and starting in early childhood rather than infancy.</p>","PeriodicalId":14930,"journal":{"name":"JIMD reports","volume":"66 3","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmd2.70017","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JIMD reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jmd2.70017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
MEGDHEL syndrome, caused by a SERAC1 gene defect, is clinically defined as the association of 3-MGA-uria (MEG), deafness (D), hepatopathy (H), encephalopathy (E), and Leigh-like features (L). Clinical presentation typically begins in the neonatal period, with neurological symptoms becoming more evident by 2 years of age. Severe liver involvement has also been reported. We report the case of a 3-year-old boy with increased transaminases and failure to thrive of unknown cause. He was born prematurely at 35 weeks and needed neonatal intensive care support for 24 h due to transient tachypnea. At 18 months, laboratory investigations for failure to thrive revealed elevated transaminases without cholestasis, which persisted on subsequent evaluations. Abdominal wall collateral veins were found during physical examination, and the liver ultrasound revealed steatosis, prompting the decision to proceed with a liver biopsy. Common causes of chronic liver disease were ruled out. Following liver biopsy, performed under general anesthesia, he had an episode of unexplained decompensation (metabolic acidosis, hyperlactatemia, and 3-methylglutaconic aciduria). The aciduria persisted upon subsequent evaluation. Liver histology showed macro/microvesicular steatosis (25%), portal tract inflammation, and mild fibrosis. Cardiac evaluation, along with brain magnetic resonance imaging and spectroscopy, was normal. Further investigations revealed decreased hepatic activity of respiratory mitochondrial chain complexes and marginal mtDNA depletion (28.1%). Analysis of the SERAC1 gene showed homozygosity for p.Y259* (c.777T>G, exon 9). This case report raises awareness for an atypical presentation of MEGDHEL syndrome associated with a homozygous nonsense variant of SERAC1 clinically characterized by mild hypertransaminasemia, failure to thrive, no neurological involvement, and starting in early childhood rather than infancy.
MEGDHEL综合征由SERAC1基因缺陷引起,临床定义为伴有3- mga -尿(MEG)、耳聋(D)、肝病(H)、脑病(E)和leigh样特征(L)。临床表现通常始于新生儿期,神经系统症状在2岁时变得更加明显。严重的肝脏受累也有报道。我们报告的情况下,3岁的男孩增加转氨酶和失败茁壮成长的原因不明。他在35周时早产,由于短暂性呼吸急促需要新生儿重症监护24小时。在18个月时,对未能茁壮成长的实验室调查显示转氨酶升高,但没有胆汁淤积,这在随后的评估中持续存在。体检时发现腹壁侧静脉,肝脏超声显示脂肪变性,促使决定进行肝活检。排除了慢性肝病的常见病因。在全身麻醉下进行肝活检后,患者出现不明原因代偿失代偿(代谢性酸中毒、高乳酸血症和3-甲基戊二酸尿)。在随后的评估中,酸尿持续存在。肝脏组织学显示大/微泡性脂肪变性(25%)、门静脉炎症和轻度纤维化。心脏评估,以及脑磁共振成像和光谱学,正常。进一步的研究显示呼吸线粒体链复合物的肝脏活性降低和边际mtDNA缺失(28.1%)。SERAC1基因分析显示p.Y259*为纯合子(c.777T>;G,外显子9)。本病例报告提高了对与SERAC1纯合无义变异相关的MEGDHEL综合征的非典型表现的认识,其临床特征为轻度高转氨血症,发育不良,无神经系统受损伤,并且开始于儿童早期而不是婴儿期。